Article

High expectations in pseudophakes fueling expansion in laser vision correction base

Demand for excellent uncorrected distance visual acuity after cataract surgery is increasing, especially with the availability of new presbyopia-correcting IOLs. This phenomenon is opening up a new class of patients to the benefits of laser vision correction, said Steven J. Dell, MD, at Refractive Surgery Day.

Demand for excellent uncorrected distance visual acuity after cataract surgery is increasing,especially with the availability of new presbyopia-correcting IOLs. This phenomenon is opening up anew class of patients to the benefits of laser vision correction, said Steven J. Dell, MD, atRefractive Surgery Subspecialty Day.

"If cataract surgery is now being considered refractive surgery, then cataract surgery withimplantation of a premium IOL is hyper-refractive surgery," said Dr. Dell, director, refractive andcorneal surgery, Texan Eye, Austin, TX. "Recipients of these lenses are less tolerant of misses inour refractive target than their younger, laser vision correction counterparts. This is because a lowhyperopic result in a young phakic patient may still result in 20/15 vision, but is totallyunacceptable in a pseudophake.

"If refractive errors occur in sphere and/or cylinder, there are a number of options for correctingthem. However, laser vision correction is the most accurate," Dr. Dell said.

When a decision is made to proceed with a laser vision enhancement, surgeons need to consider whetherto perform a customized ablation or a conventional procedure.

Dr. Dell suggested performing a wavefront-guided procedure in the eyes of patients who have receivedeither a monofocal lens, accommodating lens (crystalens, eyeonics), apodized diffractive lens(AcrySof ReSTOR, Alcon Laboratories), or multifocal lens (Tecnis, Advanced Medical Optics), assumingthe wavefront is capturable and the data make sense. However, he cautioned against a customwavefront-guided enhancement in eyes in which the zonal refractive multifocal IOL (ReZoom, AdvancedMedical Optics) is implanted.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.